Loading cancer entity…
Loading cancer entity…
Clinical trials
433 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00152269 | Treatment of Uterine Fibroids With Asoprisnil(J867) | completed | Phase 3 | 475 | AbbottINDUSTRY | 0 | May 29, 2008 | clinicaltrials |
| NCT00156195 | Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids | completed | Phase 3 | 523 | AbbottINDUSTRY | 0 | May 29, 2008 | clinicaltrials |
| NCT00156208 |
| completed |
| Phase 3 |
| 166 |
| AbbottINDUSTRY |
| 0 |
| May 29, 2008 |
| clinicaltrials |
| NCT00160381 | A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids | completed | Phase 3 | 432 | AbbottINDUSTRY | 0 | May 29, 2008 | clinicaltrials |
| NCT00160459 | A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids | completed | Phase 2 | 129 | AbbottINDUSTRY | 0 | May 29, 2008 | clinicaltrials |
| NCT00156156 | Study of Asoprisnil in the Treatment of Uterine Fibroids. | completed | Phase 3 | 149 | AbbottINDUSTRY | 0 | May 28, 2008 | clinicaltrials |
| NCT00001869 | Official Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM) | completed | — | 400 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00087841 | Self-Hypnotic Relaxation Therapy During Invasive Procedures | completed | Phase 2 | 390 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Jan 17, 2008 | clinicaltrials |
| NCT00427544 | Study of the Safety, Tolerability, and PK of PRA-027 Administered to Women of Nonchildbearing Potential | completed | Phase 1 | — | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Dec 5, 2007 | clinicaltrials |
| NCT00562471 | Safety and Efficacy Study of a Hydrogel, Applied Following Removal of Myomas During Gynecologic Surgery, Administered for the Prevention/Reduction of Postoperative Adhesion Formation | completed | Phase 1 / Phase 2 | 76 | Angiotech PharmaceuticalsINDUSTRY | 3 | Nov 22, 2007 | clinicaltrials |
| NCT00067249 | Women's Use of Alternative Medicine: A Multiethnic Study | completed | — | 3,200 | National Center for Complementary and Integrative Health (NCCIH)NIH | 0 | Feb 27, 2007 | clinicaltrials |
| NCT00100191 | Emmy Trial: Uterine Artery Embolization (UAE) Versus Hysterectomy for Uterine Fibroids | completed | Phase 3 | 120 | ZonMw: The Netherlands Organisation for Health Research and DevelopmentOTHER | 1 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated May 29, 2008source: clinicaltrials